<DOC>
	<DOC>NCT03042429</DOC>
	<brief_summary>Improvement of event free survival of high-risk neuroblastoma patients by introduction of two additional topotecan containing chemotherapy cycles into the multimodal standard treatment (induction chemotherapy, myeloablative therapy, radiation, surgery as indicated, and consolidation therapy).</brief_summary>
	<brief_title>Combination Chemotherapy Followed by Stem Cell Transplant in High-risk Neuroblastoma Patients</brief_title>
	<detailed_description>Experimental intervention (6 weeks + duration of the control intervention): 2 x N8 cycle (topotecan, cyclophosphamide, and etoposide) followed by standard arm treatment (i.e., control intervention) Control intervention (total duration 70-76 weeks): 3 x N5 cycle (cisplatin, etoposide, and vindesine) 3 x N6 cycle (vincristine, dacarbacine, ifosfamide, and doxorubicine), myeloablative chemotherapy with autologous stem cell transplantation (melphalan, carboplatin, etoposide) 9 x retinoic acid cycles (6 months, 3 months break, 3 months) supportive care (PCP/fungal prophylaxis, transfusions, antibiotics, G-CSF)</detailed_description>
	<mesh_term>Neuroblastoma</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Isophosphamide mustard</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<mesh_term>Topotecan</mesh_term>
	<mesh_term>Vindesine</mesh_term>
	<mesh_term>Isotretinoin</mesh_term>
	<criteria>neuroblastoma stage 4 neuroblastoma and age ≥1 21 years or MYCN amplification and age ≥6 months 21 years informed consent obtained Participation in other trials Pregnancy, lactation, or insufficient contraception for girls in childbearing age, Any concomitant nonprotocol anticancer therapy, Incomplete initial staging.</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>neuroblastoma</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>autologous stem cell transplantation</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>mIBG</keyword>
	<keyword>tumor resection</keyword>
</DOC>